Follow us on Twitter
twitter icon@FreshPatents


Breast Disease patents

      

This page is updated frequently with new Breast Disease-related patent applications.




 Transpapillary methods and compositions for diagnosing and treating breast conditions patent thumbnailTranspapillary methods and compositions for diagnosing and treating breast conditions
Methods and treatments are taught for the diagnosis and treatment of breast conditions, including proliferative breast disease, ductal hyperplasia, lobular hyperplasia, atypical ductal hyperplasia, atypical lobular hyperplasia, ductal carcinoma in situ, lobular carcinoma in situ, lobular carcinoma and invasive breast cancer. The methods and compositions deliver efficacious formulations of chemical and/or biological treatment medicaments to the breast via a transpapillary route..
Atossa Genetic Inc.


 Endoxifen compositions and methods patent thumbnailEndoxifen compositions and methods
The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and formulations, and use of such agents and formulations for the treatment of breast cancer and other breast diseases and diseases susceptible to endoxifen. In particular, the compositions of the present invention include liposomes, complexes, vesicles, emulsions, micelles and mixed micelles of endoxifen in which the compositions further contain any of a variety of neutral or charged lipids and desirably, cholesterol and cholesterol derivatives, sterols, z- and e-guggulsterones, phospholipids, fatty acids, vitamin d, and vitamin e.
Jina Pharmaceuticals, Inc.


 Neutralizing prolactin receptor antibody mat3 and its therapeutic use patent thumbnailNeutralizing prolactin receptor antibody mat3 and its therapeutic use
The present invention is directed to the neutralizing prolactin receptor antibody mat3, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications mediated by the prolactin receptor such as endometriosis, adenomyosis, non-hormonal female contraception, benign breast disease and mastalgia, lactation inhibition, benign prostate hyperplasia, fibroids, hyper- and normoprolactinemic hair loss, and cotreatment in combined hormone therapy to inhibit mammary epithelial cell proliferation and for the treatment and prevention of antiestrogen-resistant breast cancer. The antibody of the invention blocks prolactin receptor-mediated signalling..
Bayer Intellectual Property Gmbh


 Method and kit for discriminating between breast cancer and benign breast disease patent thumbnailMethod and kit for discriminating between breast cancer and benign breast disease
A method and kit for discriminating between breast cancer and benign breast disease by the determination of the expression level of at least one target gene having a nucleic acid sequence selected from the nucleic acid sequences set forth in seq id nos: 1, 2 or 3, 4 and 5 or 6 to obtain an expression profile for the patient, and the comparison of the expression profile of the patient with expression profiles of target genes from patients previously clinically classified as breast cancer and expression profiles of target genes from patients previously clinically classified as benign breast disease.. .
Biomerieux


 Absorbent paper and use thereof for breast cancer detection patent thumbnailAbsorbent paper and use thereof for breast cancer detection
Biological samples of mammary fluid or components thereof are obtained using a breast pump device coupled with an absorbent paper or membrane, optionally facilitated by administering oxytocin to the subject. The breast pump device stimulates expression of mammary fluid and provides for collection of diagnostic samples on the absorbent paper or membrane to evaluate breast disease, including cancer.
Atossa Genetics, Inc.


 Integrated device for breast disease diagnosis and treatment patent thumbnailIntegrated device for breast disease diagnosis and treatment
The present invention discloses an integrated device for breast disease diagnosis and treatment, which includes a control host system, and a thermalgraphy subsystem, an ultrasoudimaging subsystem and a phonophoresis subsystem respectively in communication connection with the control host system. A display terminal is electrically connected to the control host system, and the control host system further has an intelligent interpretation expert system.

 Organic compounds patent thumbnailOrganic compounds
Said compound is inhibitor of aldosterone synthase and aromatase, and thus can be employed for the treatment of a disorder or disease mediated by aldosterone synthase or aromatase. Accordingly, the compound of formula i can be used in treatment of hypokalemia, hypertension, congestive heart failure, atrial fibrillation, renal failure, in particular, chronic renal failure, restenosis, atherosclerosis, syndrome x, obesity, nephropathy, post-myocardial infarction, coronary heart diseases, inflammation, increased formation of collagen, fibrosis such as cardiac or myocardiac fibrosis and remodeling following hypertension and endothelial dysfunction, gynecomastia, osteoporosis, prostate cancer, endometriosis, uterine fibroids, dysfunctional uterine bleeding, endometrial hyperplasia, polycystic ovarian disease, infertility, fibrocystic breast disease, breast cancer and fibrocystic mastopathy.

 Absorbent paper and use thereof for breast cancer detection patent thumbnailAbsorbent paper and use thereof for breast cancer detection
Biological samples of mammary fluid or components thereof are obtained using a breast pump device coupled with an absorbent paper or membrane, optionally facilitated by administering oxytocin to the subject. The breast pump device stimulates expression of mammary fluid and provides for collection of diagnostic samples on the absorbent paper or membrane to evaluate breast disease, including cancer.

 Neutralizing prolactin receptor antibody mat3 and its therapeutic use patent thumbnailNeutralizing prolactin receptor antibody mat3 and its therapeutic use
The neutralizing prolactin receptor antibody mat3, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications mediated by the prolactin receptor such as endometriosis, adenomyosis, non-hormonal female contraception, benign breast disease and mastalgia, lactation inhibition, benign prostate hyperplasia, fibroids, hyper- and normoprolactinemic hair loss, and cotreatment in combined hormone therapy to inhibit mammary epithelial cell proliferation and for the treatment and prevention of antiestrogen-resistant breast cancer. The antibody blocks prolactin receptor-mediated signalling..



Breast Disease topics:
  • Breast Disease
  • Benign Breast
  • Epithelial Cell
  • Hormone Therapy
  • Endometriosis
  • Hyperplasia
  • Contraception
  • Adenomyosis
  • Antibodies
  • Epithelial
  • Proliferation
  • Cell Proliferation
  • Breast Cancer
  • Aldosterone
  • Endometrial


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Breast Disease for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Breast Disease with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.1003

    file did exist - 611

    0 - 1 - 12